Scientists worldwide respond to the publication of the three-volume monograph “Quantum Model of the Universe” #Physics ...

“Publish or perish” used to apply purely to faculty members, but in recent years it also has turned into a question facing academic presses — one that has particular relevance for graduate students ...

Infiniti says the QX60 Monograph is the first look at the upcoming design direction for the luxury three-row SUV and previews a production-bound vehicle to be revealed in 2021. "More than a design ...

Monograph, the leading project management software for architecture and engineering (A&E) firms, announced today it has raised a $20 million Series B funding round led by Base10 Partners. This funding ...

With a report and checklist from Monograph, architects and engineers can gain insights to improve efficiency, revenue, and other financial metrics. (Courtesy Monograph) Throughout the report simple ...

Infiniti appears ready to revive its performance credentials with plans that could bring a Red […] ...

What if the three-row QX60 had a sexier two-row sibling? You're looking at it. Infiniti's spicy FX crossover has been gone for years, but if the upcoming QX65 is any indication, it's going to be ...

Infiniti occupies a bit of an unusual space in the luxury car world. It's a brand formerly known for its delightful sport sedans and coupes, but these days, Infiniti aims to capture the quiet luxury ...

Monograph, a startup working on cloud-based software that makes project and cost management easier for architects, announced today that it has raised $1.9 million in seed funding. The round was led by ...

The Infiniti QX65 Monograph crossover coupe concept was unveiled at The Quail during Monterey Car Week. Effectively the “coupe” version of the 3-row Infiniti QX60, the concept appears production-ready ...

In practical effect, the CARES Act brought all ongoing, non-final OTC drug monograph proceedings to a close and made final FDA’s determination in “the most recently applicable proposal” under that ...

A previous article in this series focused on the questions of why and when a company would submit a monograph to the pharmacopoeias (1). This article details the more operational aspects of monograph ...